XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series C-1 Convertible Preferred Stock
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series D Convertible Preferred Stock
Preferred Stock
Invesco Asset Management
Invesco Asset Management
Common Stock
Invesco Asset Management
Additional Paid-In Capital
Private Placement
Invesco Asset Management
Private Placement
Invesco Asset Management
Common Stock
Private Placement
Invesco Asset Management
Additional Paid-In Capital
Beginning balance at Dec. 31, 2017 $ (289,546) $ 0 $ 17,731 $ (307,277) $ 23,848 $ 43,616 $ 34,382 $ 19,469 $ 68,556            
Beginning balance, shares at Dec. 31, 2017   2,082,053     12,618,279 13,801,318 8,558,686 5,037,784 80            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Equity converted 121,315 $ 0 121,315   $ (23,848) $ (43,616) $ (34,382) $ (19,469)              
Equity converted (in shares)   (1,027,079)     (12,618,279) (13,801,318) (8,558,686) (5,037,784)              
Cancellation of restricted stock awards   $ 0 0                        
Cancellation of restricted stock awards (in shares)   (122,149)                          
Issuance of stock   $ 1 47,919             $ 47,920 $ 1 $ 47,919 $ 20,000   $ 20,000
Issuance of stock (in shares)   3,968,473                 3,968,473     1,614,289  
Accretion and payment of Series D dividends (223)   (66) (157)         $ 66            
Conversion of Series D dividends and Series D 5,226 $ 1 5,225           $ (5,226)            
Conversion of Series D dividends and Series D (in shares)   (6,878,989)             (80)            
Redemption of Series D 2X liquidation preference upon conversion of Series D 80,000   80,000                        
Deemed contribution upon conversion of Series D 49,334   49,334           $ (49,334)            
Issuance of common stock and WIM Warrants 14,062   14,062           (14,062)            
Issuance of common stock and WIM Warrants (in shares)   3                          
Record pre-merger Neothetics' stockholders' equity and elimination of Neothetics' historical accumulated deficit 1,946   1,946                        
Record pre-merger Neothetics' stockholders' equity and elimination of Neothetics' historical accumulated deficit (in shares)   2,308,430                          
Issuance of common stock, pre-funded warrants and common warrants in connection with the Offering, net of underwriting discounts, commissions and offering costs 36,030 $ 1 36,029                        
Issuance of common stock, pre-funded warrants and common warrants in connection with the Offering, net of underwriting discounts, commissions and offering costs (in shares)   7,436,171                          
Issuance of common stock - exercise of stock options 42   42                        
Issuance of common stock- exercise of stock options (in shares)   6,173                          
Restricted stock awards/units issued (in shares)   1,305,399                          
Shares withheld to cover taxes related to vesting of restricted stock awards (1,526)   (1,526)                        
Shares withheld to cover taxes related to vesting of restricted stock awards (in shares)   (620,285)                          
Stock-based compensation 16,086   16,086                        
Net loss (110,731)     (110,731)                      
Ending balance at Sep. 30, 2018 $ (10,065) $ 3 $ 408,097 $ (418,165) $ 0 $ 0 $ 0 $ 0 $ 0            
Ending balance, shares at Sep. 30, 2018   25,884,625     0 0 0 0 0